Spots Global Cancer Trial Database for patient derived organoids
Every month we try and update this database with for patient derived organoids cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Precise Neoadjuvant Chemoresection of Low Grade NMIBC | NCT06227065 | Bladder Cancer Non-muscle Inva... Low-risk | Epirubicin Mitomycin Gemcitabine Docetaxel | 18 Years - | University of Bern | |
Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer | NCT05177432 | Breast Cancer | QPOP | 21 Years - 99 Years | National University Hospital, Singapore |